Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
By K. Kessenbrock, V. Plaks, Zena Werb. Cell, 2010
4,956 citations recorded by the source corpus.
Extracellular proteolysis mediates tissue homeostasis. In cancer, altered proteolysis leads to unregulated tumor growth, tissue remodeling, inflammation, tissue invasion, and metastasis. The matrix metalloproteinases (MMPs) represent the most prominent family of proteinases associated with tumorigenesis. Recent technological developments have markedly advanced our understanding of MMPs as modulators of the tumor microenvironment. In addition to their role in extracellular matrix turnover and cancer cell migration, MMPs regulate signaling pathways that control cell growth, inflammation, or angiogenesis and may even work in a nonproteolytic manner. These aspects of MMP function are reorienting our approaches to cancer therapy.
Subfields: Cancer Research, Hematology, Oncology
View Paper: https://www.semanticscholar.org/paper/58960e18b1b81c5466d2cdf1d5ab33adc8957681
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cancer Research
- Pengfei Lu
- Valerie M. Weaver
- P. E. Van den Steen
- G. Opdenakker
- K. Takai
- R. Hynes
- Alexandra Naba
- J. Vandooren
In Hematology
In Oncology
Citations in the corpus
- Aging and aging-related diseases: from molecular mechanisms to interventions and treatments (2022, background): “SASP factors secreted by senescent cells include pro-proliferation factors such as IL-6 and IL-8,(489) tissue angiogenic remodeling factors such as VEGF and CXCL5,(490,491) and pro-cancer metastasis and invasion factors such as MMPs and GDF-15.(492,493) These factors drive tumorigenesis by creating ”
- Hallmarks of cancer: the next generation. (2011, neutral): “, Figure 2) will need to be complemented by similar diagrams charting the complex interactions between the neoplastic and stromal cells within a tumor and the dynamic extracellular matrix that they collectively erect and remodel (Egeblad et al., 2010; Kessenbrock et al., 2010; Pietras and Ostman, 20”
- Apoptosis, autophagy, necroptosis, and cancer metastasis (2015, background): “tion of apoptosis in malignant cells via the cleavage of ligands or receptors in apoptotic pathways [62].”
- The 'ins' and 'outs' of podosomes and invadopodia: characteristics, formation and function (2011, neutral): “For example, inhibition of MMPs prevents primary tumour growth in many mouse models of cance”
- Tumor-associated neutrophils: new targets for cancer therapy. (2011, background): “MMP-9 (gelatinaseB) is expressed in many cell types present in the tumor microenvironment, including all hematopoietic cells and fibroblasts (25).”
- The extracellular matrix at a glance (2010, background): “MMPs, which are secreted and activated by tumor cells and by myofibroblasts (De Wever et al., 2008; Kessenbrock et al., 2010), also remodel the BM surrounding the tumor and release and activate ECM-embedded GFs (Bosman and Stamenkovic, 2003; Kessenbrock et al., 2010).”
- Balancing forces: architectural control of mechanotransduction (2011, neutral): “Altered proteolysis of the ECM by matrix metalloproteinases in cancer, a corruption of the information stored by the ECM, leads to unregulated tumour growth, inflammation and metastasi”
- Matrix MetalloProteinases (MMPs) andTissue Inhibitors of MetalloProteinases (TIMPs): positive and negative regulators intumor cell adhesion (2010, neutral): “MMPs are endopeptidases and their primary function is tissue remodeling by selective proteolytic degradation[13,14].”
- Angiogenic signaling pathways and anti-angiogenic therapy for cancer (2023, background): “The major subunits involved in tumor angiogenesis are MMP-2, MMP-9 and MMP-14.(323) MMP-2 is a 72 kDa gelatinase A or type IV collagenase that degrades types I and IV collagen.”
- Roles of the immune system in cancer: from tumor initiation to metastatic progression (2018, background): “…directly stimulate cancer cell proliferation through the secretion of epidermal growth factor (EGF) (O ’ Sullivan et al. 1993), promote tumor angiogenesis by vascular EGF (VEGF) secretion (Shojaei et al. 2008), and remodel the ECM by secreting metalloproteinases (MMPs) (Kessenbrock et al. 2010).”